Enovis (ENOV) Change in Acquisitions & Divestments (2018)

Enovis (ENOV) posted quarterly Change in Acquisitions & Divestments of $139.5 million for Q2 2018.

Enovis (ENOV) Change in Acquisitions & Divestments (2018) Analysis & Trends

Enovis (ENOV) has reported Change in Acquisitions & Divestments for 1 consecutive years, with $139.5 million the latest figure, recorded in Q2 2018.

In Q2 2018, Change in Acquisitions & Divestments changed N/A year-over-year to $139.5 million; the TTM figure through Dec 2019 stood at $139.5 million (changed 0.0% YoY), while the FY2018 annual figure was $139.5 million, changed N/A from the prior year.
Change in Acquisitions & Divestments held at $139.5 million in Q2 2018 per ENOV's latest filing.
Across five years, Change in Acquisitions & Divestments topped out at $139.5 million in Q2 2018 and bottomed at $139.5 million in Q2 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Enovis	1.50 Bn	1.48 Bn	359.25 Mn

Download Data

Date	Value
Jun 29, 2018	139.50 Mn
Jun 29, 2018	139.50 Mn